Read me this page
YOUR CHANCE TO
Win a SpaceX Ticket
Zero gravity environment even during short-term space flights puts significant strain on the body’s physiological functions, according to the National Aeronautics and Space Administration (NASA). Results of extensive biomedical research in space by NASA over the past few decades repeatedly point to the single most important need to keep the physical and mental health of their astronauts in top shape, which is to significantly improve their oxygen-rich blood circulation, especially in the smallest vessels throughout the microcirculation that webs every organ across the entire body.
The latest, fully noninvasive transdermal (over-the-skin) rapid and painless drug infusion technology by Circularity Healthcare called D’OXYVA (deoxyhemoglobin vasodilator) is hailed as a game changer by world-class medical experts from the top ten U.S. and international universities and hospitals.
D’OXYVA (pron. doxeeva) has been demonstrating unparalleled results in significantly improved oxygen-rich microcirculatory blood flow in Phase 3 human trials with its platform FDA-approved simple and non-toxic molecules for over five years. It stands out with outstanding clinical outcomes and zero major adverse side-effect reports after years of research conducted by some of the world’s leading medical experts.
The over-the-counter (OTC) version of D’OXYVA is now available for purchase exclusively on its website at: doxyva.com.
Watch short video below.